Gold nanoparticles improve effectiveness of medicines
Researchers at the University of Geneva (UNIGE), in collaboration with other institutions, have successfully highlighted the impact of gold nanoparticles on B lymphocytes.
This content was published on
2 minutes
Keystone-SDA/ts
These results, published in the journal ACS NanoExternal link, should pave the way for more effective vaccines and therapies.
B-cells are a crucial part of the immune system and thus an attractive target for vaccine development. However, to fulfil their goal, vaccines must reach B cells quickly without being destroyed en route, UNIGE said in a statement on Friday.
This is where the use of nanoparticles can be interesting.
“Nanoparticles can form a protective vehicle for vaccines – or other drugs – to specifically deliver them where they can be most effective, while sparing other cells,” explained Carole Bourquin, professor at UNIGE’s Faculties of Medicine and ScienceExternal link, who co-led the study.
“This targeting also allows the use of a lower dose of immunostimulant while maintaining an effective immune response. It increases its efficacy while reducing side-effects, provided that the nanoparticles are harmless to all immune cells.”
Golden opportunity
Gold is an excellent candidate for nanomedicine because of its particular physico-chemical properties, the authors wrote. Well tolerated by the body and easily malleable, this metal has, for instance, the particularity of absorbing light and then releasing heat, a property that can be exploited in oncology.
“Gold nanoparticles can be used to target tumours. When exposed to a light source, the nanoparticles release heat and destroy neighbouring cancer cells. We could also attach a drug to the surface of the nanoparticles to be delivered to a specific location,” said UNIGE researcher Sandra Hočevar.
The gold nanoparticles developed by the team of researchers could make it possible to deliver existing drugs directly to B lymphocytes to reduce the necessary dosage and potential side effects. In fact, studies in patients are already being carried out for the treatment of brain tumours, the researchers said.
More
More
Cancer in the crosshairs
This content was published on
Switzerland has joined an unprecedented scientific collaboration to accelerate nanomedicine testing in a bid to conquer a common enemy: cancer.
Switzerland invites 160 delegations to June Ukraine peace talks
This content was published on
Russia is currently not among the delegations invited to talks aimed at helping bring about peace in the conflict between Moscow and Ukraine.
Survey: air travel most popular way to go on holidays for Swiss
This content was published on
Despite the climate crisis, flying is the most popular mode of transport for private travel – particularly among young, urban and high-income travellers.
Swiss government to use phone data to identify asylum seekers
This content was published on
From April 2025, authorities plan to be able to analyse data from mobile phones, computers and other data carriers to identify asylum seekers.
Young undocumented migrants gain easier access to vocational training
This content was published on
Rejected asylum-seekers and young undocumented migrants in Switzerland will have easier access to basic vocational training from June 1.
Migration: Swiss government wants to shorten reunification period for families
This content was published on
Family members of people temporarily admitted to Switzerland should in future be able to join them after two years instead of three.
This content was published on
2023 was a record year for the Rhaetian Railway in several respects. Never before has the narrow-gauge railway in Graubünden, eastern Switzerland, transported so many passengers and cars.
Swiss CFOs much more optimistic despite global uncertainty
This content was published on
The main concerns of business leaders in Switzerland are geopolitical uncertainty and the important trading partners Germany and China.
Study finds nanoparticles in over one-quarter of foodstuffs
This content was published on
Nanoparticles were found in over one-quarter of the foodstuffs tested in a pilot study carried out in French-speaking Switzerland.
This content was published on
Lukas Novotny and his ETHZ collaborators at the Institute for Photonics manipulated a minuscule piece of glass only a hundred nanometres in size – a thousand times smaller than a hair – in such a way as to make it turn around its own axis more than a billion times a second. The results of…
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.